Sponsored Sessions

(Please note this programme is subject to change)

Change your timezone preference

Day 1- Friday, 17 October

10:10 AM - 10:50 AM (BST)
Meet the Expert
GDMT Implementation in HF – Bridging the Gap

  • Bridging the Implementation Gap in HF: Strategies to Improve Guideline Adherence – Biykem Bozkurt

  • In-hospital Initiation of GDMT: A Window of Opportunity – David Berg

 



Supported by unrestricted educational grant funding from AstraZeneca


1:00 PM - 1:50 PM (BST)
Symposium
Beyond the Cornerstone: SGLT2 Inhibitors Shaping the Future of Heart Failure Care

Chairs – Stefan Anker and Maria Rosa Costanzo

  • SGLT2 Inhibitors in HF Prevention and Treatment: Clinical Trial Evidence – Giuseppe Rosano

  • Translating the Benefits of SGLT2 Inhibitors Therapy into Daily Care: Which Strategies to Improve Implementation – Shahzeb Khan

  • Looking Ahead in Heart Failure: SGLT2 Inhibitors and Combination Therapies – Maria Rosa Costanzo

 



Supported by an unrestricted educational grant from Boehringer Ingelheim


3:10 PM - 3:50 PM (BST)
Meet the Expert
REPLAY: GDMT Implementation in HF – Bridging the Gap

  • Bridging the Implementation Gap in HF: Strategies to Improve Guideline Adherence – Biykem Bozkurt

  • In-hospital Initiation of GDMT: A Window of Opportunity – David Berg



Supported by unrestricted educational grant funding from AstraZeneca


5:10 PM - 5:50 PM (BST)
Meet the Expert
Implementing Guidelines for ATTR-CM Diagnosis and Management: A Case-based Discussion

Olivier Lairez and Ahmad Masri

  • Early Recognition of ATTR-CM in HF Care

  • Implications of ATTR-CM for HF Management and Evolving Treatment Landscape



Supported by unrestricted educational grant funding from AstraZeneca


5:50 PM - 7:00 PM (BST)
Meet the Expert
Cardiac Rhythm Devices in HFrEF ‒ Role, Timing, and Optimal Use in Contemporary Practice

Chair – Javed Butler

Speakers – Biykem Bozkurt, Christophe Leclercq, Wilfried Mullens, Andrea Russo, Gianluigi Savarese and Shelley Zieroth



The DIRECT HF educational programme is supported by Medtronic


8:10 PM - 8:50 PM (BST)
Meet the Expert
REPLAY: Implementing Guidelines for ATTR-CM Diagnosis and Management: A Case-based Discussion

Olivier Lairez and Ahmad Masri

  • Early Recognition of ATTR-CM in HF Care

  • Implications of ATTR-CM for HF Management and Evolving Treatment Landscape

 



Supported by unrestricted educational grant funding from AstraZeneca



Register for free

Day 2 - Saturday, 18 October

10:10 AM - 10:50 AM (BST)
Meet the Expert
Practical Aspects of NSMRA Use in HF

Muthiah Vaduganathan and Gianluigi Savarese



Supported by an unrestricted educational grant from Bayer


1:10 PM - 1:50 PM (BST)
Symposium
REPLAY: Beyond the Cornerstone: SGLT2 Inhibitors Shaping the Future of Heart Failure Care

Chairs – Stefan Anker and Maria Rosa Costanzo

  • SGLT2 Inhibitors in HF Prevention and Treatment: Clinical Trial Evidence – Giuseppe Rosano

  • Translating the Benefits of SGLT2 Inhibitors Therapy into Daily Care: Which Strategies to Improve Implementation – Shahzeb Khan

  • Looking Ahead in Heart Failure: SGLT2 Inhibitors and Combination Therapies – Maria Rosa Costanzo

 



Supported by an unrestricted educational grant from Boehringer Ingelheim


3:10 PM - 3:50 PM (BST)
Meet the Expert
SGLT2 Inhibitors in HF Management: The Present and the Future

  • Role of SGLT2 Inhibitors in the Management of HF Across the Ejection Fraction Spectrum – Shelley Zieroth

  • Practical Guidance for the Use of SGLT2 Inhibitors in Patients With HF Future Perspectives (Including Combination Therapies) – Maria Rosa Costanzo



Supported by an unrestricted educational grant from Boehringer Ingelheim



Register for free

If you’re interested in becoming an educational partner or sponsor at this event, please contact sales@radcliffe-group.com

Sponsors

About Translational Medicine Academy

Our ambition at the Translational Medicine Academy® (TMA) is to bring medical findings from bench to bedside and into the working lives of physicians and the care of patients. In seeking to improve therapeutic approaches, TMA works with its International Scientific Advisory Board on Critical Mission Areas® of public health importance in domains where there are educational shortcomings among physicians and unmet healthcare needs among patients.

Gathered around a Scientific Advisory Board of experts, the Translational Medicine Academy is an international non-profit Foundation with headquarter in Basel, and offices in Paris, and the US. TMA’s funding includes private donations from individuals and educational grants from governments, non-governmental organizations and corporations.

For more information on TMA, please visit www.tmacademy.org.

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking


Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com